Matinas Biopharma I (MTNB) – Trading Update
- Last Trading Session: 21 Wednesday, 01:13 PM Central Europe time
- Price Movement: +2.41 % over the 24‑hour period
- Current Price: USD 1.70 per share
- Shares Outstanding: 981,900
- Market Capitalisation: USD 1.6 million
- Volume (last 24 h): USD 81,400
- Year‑to‑Date Performance: +877.01 % since the end of last month
- 200‑Day Simple Moving Average: USD 0.77
- 52‑Week Range:
- High: USD 6.60 (29 July 2026)
- Low: USD 0.15 (15 September 2026)
Related Stock Performance (Last 24 Hours)
| Ticker | Current Price | % Change | Market Cap |
|---|---|---|---|
| AOTI.L (Aoti) | GBX 135 | 0 % | GBX 184 million |
| OGEN (Oragenics) | USD 0.43 | +2.38 % | USD 1.9 million |
| KAPA (Kairos Pharma) | USD 0.58 | +2.46 % | USD 1.9 million |
| SILO (Silo Pharma) | USD 1.20 | +6.19 % | USD 1.8 million |
| REVB (Revelation Biosciences) | USD 3.75 | +14.16 % | USD 1.9 million |
Company Overview
Matinas BioPharma Holdings, Inc.
- Industry: Biotechnology (Health Care sector)
- Headquarters: Bedminster, United States
- Business Model: Provides clinical‑stage biopharmaceutical services through subsidiary companies.
- Key Focus Areas: Small‑molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicinal products.
- Website: www.matinasbiopharma.com
- Exchange Listing: NYSE MKT
